Max Historical Income Statement

MAXHEALTH

988.45 14.65 1.50%

Historical analysis of Max Healthcare income statement accounts such as Total Revenue of 65.3 B can show how well Max Healthcare Institute performed in making a profits. Evaluating Max Healthcare income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Max Healthcare's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Max Healthcare Institute latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Max Healthcare Institute is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Max Healthcare Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About Max Income Statement Analysis

Max Healthcare Institute Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Max Healthcare shareholders. The income statement also shows Max investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Max Healthcare Income Statement Chart

At this time, Max Healthcare's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 17.2 B this year, although the value of Total Other Income Expense Net is projected to rise to (7.4 B).

Interest Expense Selling And Marketing Expenses Total Revenue Reconciled Depreciation Minority Interest

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Max Healthcare Institute generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Max Healthcare Institute whose combined shares represent less than 50% of the total outstanding shares issued by Max Healthcare have a minority interest in Max Healthcare.

Most accounts from Max Healthcare's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Max Healthcare Institute current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Max Healthcare Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2022	2023	2024	2025 (projected)
Interest Expense	838.6M	598.9M	688.7M	954.1M
Depreciation And Amortization	2.3B	2.4B	2.8B	3.0B

Interest Expense Depreciation And Amortization

Max Healthcare income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Tax Provision	Net Interest Income	Interest Income	Discontinued Operations	Net Income From Continuing Ops	Reconciled Depreciation	Research Development
Depreciation And Amortization		0.26	0.8	0.97	0.97	0.88	0.91	0.95	0.96	0.86	0.68	0.93	-0.63	0.91	0.81	0.96	0.81	0.64	0.95	-0.63	0.91	0.92	0.84
Interest Expense	0.26		0.0	0.22	0.33	0.33	0.06	0.08	0.1	-0.01	0.59	0.04	0.11	0.04	0.03	0.38	0.03	-0.33	0.16	-0.08	0.02	0.21	-0.01
Selling And Marketing Expenses	0.8	0.0		0.88	0.78	0.59	0.97	0.9	0.89	0.98	0.19	0.9	-0.7	0.85	0.96	0.81	0.97	0.87	0.91	-0.8	0.85	0.71	0.86
Total Revenue	0.97	0.22	0.88		0.98	0.86	0.97	0.99	0.99	0.93	0.61	0.98	-0.71	0.96	0.87	0.97	0.87	0.75	0.98	-0.69	0.96	0.91	0.91
Gross Profit	0.97	0.33	0.78	0.98		0.92	0.9	0.96	0.96	0.83	0.75	0.94	-0.64	0.94	0.76	0.98	0.76	0.65	0.93	-0.6	0.94	0.92	0.87
Other Operating Expenses	0.88	0.33	0.59	0.86	0.92		0.74	0.83	0.85	0.66	0.81	0.82	-0.57	0.84	0.59	0.89	0.59	0.48	0.81	-0.28	0.83	0.96	0.75
Operating Income	0.91	0.06	0.97	0.97	0.9	0.74		0.97	0.97	0.99	0.38	0.97	-0.75	0.94	0.94	0.9	0.94	0.85	0.97	-0.76	0.94	0.84	0.92
Ebit	0.95	0.08	0.9	0.99	0.96	0.83	0.97		1.0	0.94	0.55	1.0	-0.75	0.99	0.87	0.94	0.87	0.82	0.97	-0.69	0.99	0.9	0.93
Ebitda	0.96	0.1	0.89	0.99	0.96	0.85	0.97	1.0		0.94	0.57	0.99	-0.74	0.98	0.87	0.95	0.87	0.8	0.97	-0.69	0.98	0.9	0.93
Cost Of Revenue	0.86	-0.01	0.98	0.93	0.83	0.66	0.99	0.94	0.94		0.27	0.94	-0.77	0.9	0.96	0.83	0.96	0.85	0.95	-0.79	0.9	0.79	0.88
Total Operating Expenses	0.68	0.59	0.19	0.61	0.75	0.81	0.38	0.55	0.57	0.27		0.51	-0.22	0.57	0.19	0.72	0.19	0.1	0.5	-0.13	0.56	0.67	0.45
Income Before Tax	0.93	0.04	0.9	0.98	0.94	0.82	0.97	1.0	0.99	0.94	0.51		-0.76	0.99	0.87	0.92	0.87	0.84	0.96	-0.7	0.99	0.88	0.94
Total Other Income Expense Net	-0.63	0.11	-0.7	-0.71	-0.64	-0.57	-0.75	-0.75	-0.74	-0.77	-0.22	-0.76		-0.76	-0.62	-0.56	-0.62	-0.71	-0.78	0.47	-0.77	-0.7	-0.84
Net Income	0.91	0.04	0.85	0.96	0.94	0.84	0.94	0.99	0.98	0.9	0.57	0.99	-0.76		0.8	0.91	0.79	0.83	0.94	-0.65	1.0	0.88	0.95
Income Tax Expense	0.81	0.03	0.96	0.87	0.76	0.59	0.94	0.87	0.87	0.96	0.19	0.87	-0.62	0.8		0.8	1.0	0.75	0.89	-0.77	0.8	0.73	0.75
Selling General Administrative	0.96	0.38	0.81	0.97	0.98	0.89	0.9	0.94	0.95	0.83	0.72	0.92	-0.56	0.91	0.8		0.8	0.65	0.92	-0.63	0.9	0.88	0.83
Tax Provision	0.81	0.03	0.97	0.87	0.76	0.59	0.94	0.87	0.87	0.96	0.19	0.87	-0.62	0.79	1.0	0.8		0.75	0.89	-0.77	0.8	0.73	0.74
Net Interest Income	0.64	-0.33	0.87	0.75	0.65	0.48	0.85	0.82	0.8	0.85	0.1	0.84	-0.71	0.83	0.75	0.65	0.75		0.76	-0.67	0.83	0.57	0.89
Interest Income	0.95	0.16	0.91	0.98	0.93	0.81	0.97	0.97	0.97	0.95	0.5	0.96	-0.78	0.94	0.89	0.92	0.89	0.76		-0.71	0.94	0.9	0.92
Discontinued Operations	-0.63	-0.08	-0.8	-0.69	-0.6	-0.28	-0.76	-0.69	-0.69	-0.79	-0.13	-0.7	0.47	-0.65	-0.77	-0.63	-0.77	-0.67	-0.71		-0.65	-0.4	-0.62
Net Income From Continuing Ops	0.91	0.02	0.85	0.96	0.94	0.83	0.94	0.99	0.98	0.9	0.56	0.99	-0.77	1.0	0.8	0.9	0.8	0.83	0.94	-0.65		0.88	0.95
Reconciled Depreciation	0.92	0.21	0.71	0.91	0.92	0.96	0.84	0.9	0.9	0.79	0.67	0.88	-0.7	0.88	0.73	0.88	0.73	0.57	0.9	-0.4	0.88		0.81
Research Development	0.84	-0.01	0.86	0.91	0.87	0.75	0.92	0.93	0.93	0.88	0.45	0.94	-0.84	0.95	0.75	0.83	0.74	0.89	0.92	-0.62	0.95	0.81

Click cells to compare fundamentals

Max Healthcare Account Relationship Matchups

Max Healthcare income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	1.7B	2.2B	2.3B	2.4B	2.8B	3.0B
Interest Expense	1.7B	900.1M	838.6M	598.9M	688.7M	954.1M
Selling And Marketing Expenses	167.5M	446.2M	575.5M	3.7B	4.3B	4.5B
Total Revenue	24.8B	38.8B	45.6B	54.1B	62.2B	65.3B
Gross Profit	18.9B	29.6B	36.4B	33.5B	38.6B	40.5B
Other Operating Expenses	22.0B	31.1B	35.5B	31.7B	36.5B	21.4B
Operating Income	2.4B	7.6B	10.2B	22.4B	25.7B	27.0B
Ebit	1.1B	8.4B	11.5B	14.3B	16.4B	17.2B
Ebitda	2.8B	10.6B	13.8B	16.7B	19.2B	20.2B
Cost Of Revenue	5.9B	9.2B	9.2B	20.5B	23.6B	24.8B
Total Operating Expenses	16.0B	21.8B	26.3B	11.2B	12.9B	13.9B
Income Before Tax	(686.5M)	7.4B	10.6B	13.7B	15.7B	16.5B
Total Other Income Expense Net	(3.2B)	(1.9B)	(7.8B)	(8.7B)	(7.8B)	(7.4B)
Net Income	(1.4B)	6.1B	11.0B	10.6B	12.2B	12.8B
Income Tax Expense	458.5M	1.3B	(397.9M)	3.1B	3.5B	3.7B
Selling General Administrative	5.8B	9.1B	9.9B	11.2B	12.8B	13.5B
Tax Provision	458.5M	1.3B	(397.9M)	3.1B	3.5B	3.7B
Net Interest Income	(1.8B)	(1.0B)	285.2M	963.1M	1.1B	1.2B
Interest Income	767.3M	750.9M	1.1B	1.6B	1.8B	1.9B
Net Income From Continuing Ops	(1.1B)	6.1B	11.0B	10.6B	12.2B	12.8B
Reconciled Depreciation	1.7B	2.2B	2.3B	2.4B	2.8B	1.9B
Net Income Applicable To Common Shares	589.9M	(1.4B)	6.1B	11.0B	12.7B	13.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Max Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Max Historical Income Statement

About Max Income Statement Analysis

Max Healthcare Income Statement Chart

Interest Expense

Total Revenue

Minority Interest

Max Healthcare income statement Correlations

Max Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Max Healthcare income statement Accounts

Also Currently Popular

Other Information on Investing in Max Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income From Continuing Ops	+ 1.0	Net Income
Tax Provision	+ 1.0	Income Tax Expense
Ebit	+ 0.99	Total Revenue
Ebitda	+ 0.99	Total Revenue

Research Development	- 0.84	Total Other Income Expense Net
Discontinued Operations	- 0.8	Selling And Marketing Expenses
Discontinued Operations	- 0.79	Cost Of Revenue
Interest Income	- 0.78	Total Other Income Expense Net
Discontinued Operations	- 0.77	Tax Provision
Discontinued Operations	- 0.77	Income Tax Expense